Residual HCV-RNA and Elevated Platelet-to-Lymphocyte Ratio Predict Poor Long-Term Outcomes in Patients with Chronic Hepatitis C After Treatment. [PDF]
Wróblewska A +7 more
europepmc +1 more source
Whole Lotta Lipids-from HCV RNA Replication to the Mature Viral Particle. [PDF]
Bley H, Schöbel A, Herker E.
europepmc +1 more source
ABSTRACT The introduction of potent, well‐tolerated direct‐acting antivirals (DAAs) has transformed hepatitis C virus (HCV) therapy and spurred global elimination efforts. However, the extensive genetic diversity of HCV may affect antiviral efficacy, particularly in low and middle‐income regions where limited data currently exist.
Win Min Han +11 more
wiley +1 more source
HCV RNA positivity among hepatitis C patients in Chongqing, China from 2004 to 2021: a cross-sectional study. [PDF]
He Y +6 more
europepmc +1 more source
ABSTRACT Background and Aims To achieve hepatitis C (HCV) elimination by 2030, testing and treatment must reach people most at risk. Dried blood spot (DBS) testing offers an alternative to venepuncture, suitable for community and prison settings. This study evaluated HCV infection prevalence and treatment initiation among people receiving DBS testing ...
Annabelle Stevens +12 more
wiley +1 more source
A systematic PCR record-based re-call of HCV-RNA-positive people enables re-linkage to care and HCV elimination in Austria - The ELIMINATE project. [PDF]
Balcar L +36 more
europepmc +1 more source
Potato virus Y (PVY) coat protein (CP) interacts with cytosolic phosphoglucomutase (cPGM) in the cytosol, redirecting carbohydrate flux towards respiratory and pentose phosphate pathways. Consequently, the plant cell can meet the increased ATP, NADPH and biosynthetic precursor requirements for viral RNA synthesis, thereby promoting PVY accumulation and
Prabu Gnanasekaran +2 more
wiley +1 more source
Post-Diagnosis HCV RNA Testing Rates Prior to HCV Treatment Among People Living With HIV With HCV Antibody Positivity in the Asia-Pacific Region. [PDF]
Rupasinghe D +13 more
europepmc +1 more source
Direct-acting antivirals ability to clear intestinal HCV-RNA in liver transplant patients. [PDF]
Pietrosi G +8 more
europepmc +1 more source
Immune Checkpoint Inhibitor Can Reduce HCV-RNA without Liver Damage. [PDF]
Fukuda R, Sugawara S, Kondo Y.
europepmc +1 more source

